ro compounded glp-1 launches insurance coverage checker Ro's Weight-Loss Program Review: GLP-1

Patients switching from liraglutide to semaglutide should stop liraglutide on the day of the first semaglutide 0.25 mg dose

You can also track meals, calorie intake, and physical activity to better understand how your lifestyle adjustments are influencing your tapering process

Looking for a headline-worthy haul

The integrated experience supports ongoing care management, treatment adherence and individualized journeys, Ro executives said

Actual medications may vary depending on the prescribing provider, pharmacy, and applicable regulations

The lineup includes the Wegovy pill (oral semaglutide, FDA-approved December 2025, launched January 2026, the first FDA-approved oral GLP-1 for weight loss in adults), the Wegovy pen (injectable semaglutide 2.4 mg), Zepbound (tirzepatide via LillyDirect), and Ozempic (off-label for weight loss)